David Campen

1.4k total citations · 1 hit paper
11 papers, 1.1k citations indexed

About

David Campen is a scholar working on Pharmacology, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, David Campen has authored 11 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pharmacology, 4 papers in Cardiology and Cardiovascular Medicine and 3 papers in Surgery. Recurrent topics in David Campen's work include Inflammatory mediators and NSAID effects (4 papers), Antiplatelet Therapy and Cardiovascular Diseases (3 papers) and Drug-Induced Adverse Reactions (2 papers). David Campen is often cited by papers focused on Inflammatory mediators and NSAID effects (4 papers), Antiplatelet Therapy and Cardiovascular Diseases (3 papers) and Drug-Induced Adverse Reactions (2 papers). David Campen collaborates with scholars based in United States. David Campen's co-authors include David J. Graham, Rita L. Hui, Michele M. Spence, Stanford Shoor, Gerald Levy, Wayne A. Ray, Craig Cheetham, Francisco P. Quismorio, Martin Wj and David A. Horwitz and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Health Affairs.

In The Last Decade

David Campen

10 papers receiving 998 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study

2005 683 citations David J. Graham, David Campen et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Campen United States	9	496	259	202	159	129	11	1.1k
Heather Halls Australia	8	700 1.4×	460 1.8×	428 2.1×	117 0.7×	149 1.2×	13	1.6k
Ruth Savage New Zealand	15	577 1.2×	151 0.6×	294 1.5×	109 0.7×	124 1.0×	33	1.2k
Dan Pettitt United States	13	427 0.9×	242 0.9×	156 0.8×	86 0.5×	270 2.1×	15	1.3k
Patrice Matchaba Switzerland	9	869 1.8×	405 1.6×	252 1.2×	53 0.3×	141 1.1×	13	1.3k
Federica Nicotra Italy	16	463 0.9×	487 1.9×	331 1.6×	89 0.6×	124 1.0×	21	1.5k
Yuka Kiyota United States	4	302 0.6×	388 1.5×	142 0.7×	66 0.4×	85 0.7×	5	937
Gerald Levy United States	11	476 1.0×	257 1.0×	262 1.3×	34 0.2×	204 1.6×	17	1.1k
Søren Rasmussen Denmark	13	429 0.9×	1.0k 3.9×	323 1.6×	96 0.6×	81 0.6×	27	1.9k
Vera E. Valkhoff Netherlands	17	377 0.8×	543 2.1×	458 2.3×	206 1.3×	63 0.5×	39	1.5k
Deborah Layton United Kingdom	24	342 0.7×	203 0.8×	77 0.4×	57 0.4×	69 0.5×	64	1.1k

Countries citing papers authored by David Campen

Since Specialization

Citations

This map shows the geographic impact of David Campen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Campen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Campen more than expected).

Fields of papers citing papers by David Campen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Campen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Campen. The network helps show where David Campen may publish in the future.

Co-authorship network of co-authors of David Campen

This figure shows the co-authorship network connecting the top 25 collaborators of David Campen. A scholar is included among the top collaborators of David Campen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Campen. David Campen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

1.

Schottinger, Joanne E., et al.. (2013). Kaiser Permanente HealthConnect Oncology Beacon module.. Journal of Clinical Oncology. 31(31_suppl). 238–238.

2.

Graham, David J., David Campen, Rita L. Hui, et al.. (2008). Myocardial Infarction and Its Association with the Use of Nonselective NSAIDs: A Nested Case-Control and Time-to-Event Analysis. The Permanente Journal. 12(1). 16–22. 8 indexed citations

3.

Graham, David J., David Campen, Rita L. Hui, et al.. (2005). Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study. The Lancet. 365(9458). 475–481. 683 indexed citations breakdown →

4.

Graham, David J., David Campen, & Hui Ren. (2005). Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal inflammatory drugs: Nested case-control study. Journal of Vascular Surgery. 41(5). 911–911. 2 indexed citations

5.

Graham, David J., David Campen, & Rutai Hui. (2005). Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclooxygenase-2 selective and non-selective non-steroidal anti-inflammatory drugs: Nested case-control study. ACC Current Journal Review. 14(4). 12–13. 61 indexed citations

6.

Bull, Scott, Carol Conell, & David Campen. (2002). Relationship of Clinical Factors to the Use of Cox-2 Selective NSAIDs Within an Arthritis Population in a Large HMO. Journal of Managed Care Pharmacy. 8(4). 252–258. 12 indexed citations

7.

Levine, Sharon A., et al.. (2000). Kaiser Permanente's Prescription Drug Benefit. Health Affairs. 19(2). 185–190. 18 indexed citations

8.

Weaver, Fred A., Albert E. Yellin, David Campen, et al.. (1990). Surgical procedures in the management of Takayasu's arteritis. Journal of Vascular Surgery. 12(4). 429–439. 74 indexed citations

9.

Weaver, Fred A., Albert E. Yellin, David Campen, et al.. (1990). Surgical procedures in the management of Takayasu's arteritis. Journal of Vascular Surgery. 12(4). 429–439. 65 indexed citations

10.

Campen, David, et al.. (1990). Candida septic arthritis in rheumatoid arthritis.. PubMed. 17(1). 86–8. 23 indexed citations

11.

Campen, David, David A. Horwitz, Francisco P. Quismorio, Glenn R. Ehresmann, & Martin Wj. (1988). Serum levels of interleukin‐2 receptor and activity of rheumatic diseases characterized by immune system activation. Arthritis & Rheumatism. 31(11). 1358–1364. 118 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact